Furthermore, liraglutide enhances the susceptibility of gemcitabine-resistant pancreatic cancer cells to apoptosis by downregulating ATP-binding cassette transporter G2 (ABCG2) via NF-κB signaling [75]. This evidence concerns the gene NFKB1 and pancreatic neoplasm.